$244.68
0.07% yesterday
NYSE, Nov 25, 10:10 pm CET
ISIN
US70975L1070
Symbol
PEN

Penumbra, Inc. Stock price

$244.68
+39.97 19.53% 1M
+51.02 26.35% 6M
-6.86 2.73% YTD
+13.66 5.91% 1Y
-15.30 5.89% 3Y
+72.85 42.40% 5Y
+203.38 492.45% 10Y
NYSE, Closing price Mon, Nov 25 2024
-0.16 0.07%
ISIN
US70975L1070
Symbol
PEN
Sector

Key metrics

Market capitalization $9.39b
Enterprise Value $9.33b
P/E (TTM) P/E ratio 284.15
EV/FCF (TTM) EV/FCF 69.51
EV/Sales (TTM) EV/Sales 8.01
P/S ratio (TTM) P/S ratio 8.07
P/B ratio (TTM) P/B ratio 8.50
Revenue growth (TTM) Revenue growth 16.96%
Revenue (TTM) Revenue $1.16b
EBIT (operating result TTM) EBIT $78.48m
Free Cash Flow (TTM) Free Cash Flow $134.18m
Cash position $291.02m
EPS (TTM) EPS $0.86
P/E forward 584.31
P/S forward 7.89
EV/Sales forward 7.83
Short interest 8.32%
Show more

Is Penumbra, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Penumbra, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Penumbra, Inc. forecast:

12x Buy
63%
6x Hold
32%
1x Sell
5%

Analyst Opinions

19 Analysts have issued a Penumbra, Inc. forecast:

Buy
63%
Hold
32%
Sell
5%

Financial data from Penumbra, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,164 1,164
17% 17%
100%
- Direct Costs 440 440
19% 19%
38%
724 724
16% 16%
62%
- Selling and Administrative Expenses 519 519
14% 14%
45%
- Research and Development Expense 97 97
20% 20%
8%
108 108
23% 23%
9%
- Depreciation and Amortization 30 30
11% 11%
3%
EBIT (Operating Income) EBIT 78 78
27% 27%
7%
Net Profit 35 35
15% 15%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Penumbra, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Penumbra, Inc. Stock News

Neutral
PRNewsWire
6 days ago
ALAMEDA, Calif. , Nov. 20, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024.
Neutral
PRNewsWire
21 days ago
Data presented for the first time this week at Vascular Interventional Advances (VIVA) 2024 Conference Findings reinforce the clinical, health economic and cost benefits of computer assisted vacuum thrombectomy to patients and the overall health system ALAMEDA, Calif. , Nov. 5, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced new data that dem...
Neutral
Seeking Alpha
26 days ago
Penumbra, Inc. (NYSE:PEN ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Cecilia Furlong - Director of Business Development and Investor Relations Adam Elsesser - Chairman and Chief Executive Officer Maggie Yuen - Chief Financial Officer Jason Mills - Executive Vice President of Strategy Conference Call Participants Richard Newitter - Truist Securities Robert...
More Penumbra, Inc. News

Company Profile

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products. Its target markets include interventional neuroradiologists, neurosurgeons, and interventional neurologists; and interventional radiologists, vascular surgeons, and interventional cardiologists. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.

Head office United States
CEO Adam Elsesser
Employees 4,200
Founded 2004
Website www.penumbrainc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today